Launch
Website- Bupa Platinum consultant
- Fee assured
- Awaiting verification
- Open Referral network
Specialises in
- Colon
- Lung
- Upper GI
Offers
- Video and telephone consultations
About me
General medical training in London. Oncology training 5yrs at The Royal Marsden, 2 Years in Leeds
Appointed as a consultant 1994
Qualifications BA 1979, MA 1982, MRCP 1985, FRCP 1995, FRCR 1989
Major contributor to national randomised trials in gastro-intestinal and lung cancer
Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial. Lancet Oncology 17; 8, p1094–1104
I was Clinical Director 2011-2017 and Cancer Lead from 1994-2017. I sit on the Faculty board of the Royal College of radiologists.
I have been involved in education throughout my career, as Tutor, Educational Supervisor and deputy regional advisor. I examined for the FRCR 2006-2012
Areas of interest
Colorectal; Upper GI; Lung; Sarcoma
Medical secretaries
- Donna Gardner
- Berkshire Oncology Partnership Spire Dunedin Hospital 13 Bath Road READING RG1 6HH
- 0118 955 3531
- 0118 955 3519
- practicemanager@berkshire-oncology.org.uk
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X0004
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)
Spire Dunedin Hospital (5-50)
-
X0003
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)
Spire Dunedin Hospital (5-50)
-
X0002
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-14 days - (1-5)
Spire Dunedin Hospital (1-5)